The concept rests on assumptions that are unsupported by evidence. Consequently, current proposals for mandatory ...
Certain features of the drugs selected for first-year negotiation could limit CMS’s pricing flexibility. To enhance program predictability and provide clear signals to the pharmaceutical industry ...
The Association for Accessible Medicines (AAM) said the US Food and Drug Administration (FDA) should ensure alignment between the International Council on Harmonisation’s (ICH) M13A guidance on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results